LeonaBio (LONA) Cash from Investing Activities Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -122.45% |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | -111.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -111.40% |
| Dec 31, 2025 | -420.55% |
| Sep 30, 2025 | -68.66% |
| Jun 30, 2025 | -98.34% |
| Mar 31, 2025 | -156.37% |
| Dec 31, 2024 | -144.00% |
| Sep 30, 2024 | -12.81% |
| Jun 30, 2024 | -18.24% |
| Mar 31, 2024 | -63.29% |
| Dec 31, 2023 | -74.07% |
| Sep 30, 2023 | 51.78% |
| Jun 30, 2023 | 828.22% |
| Mar 31, 2023 | 48.96% |
| Dec 31, 2022 | 15.32% |
| Sep 30, 2022 | 196.01% |
| Jun 30, 2022 | -138.94% |
| Mar 31, 2022 | 205.01% |
| Dec 31, 2021 | 118.46% |
| Sep 30, 2021 | 84.94% |
| Jun 30, 2021 | 572,650.00% |
| Mar 31, 2021 | -2,270,900.00% |
| Dec 31, 2020 | -15,513.85% |